Literature DB >> 29092819

Protein arginine methyltransferase expression, localization, and activity during disuse-induced skeletal muscle plasticity.

Derek W Stouth1, Alexander Manta1, Vladimir Ljubicic1.   

Abstract

Protein arginine methyltransferase 1 (PRMT1), PRMT4, and PRMT5 catalyze the methylation of arginine residues on target proteins. Previous work suggests that these enzymes regulate skeletal muscle plasticity. However, the function of PRMTs during disuse-induced muscle remodeling is unknown. The purpose of our study was to determine whether denervation-induced muscle disuse alters PRMT expression and activity in skeletal muscle, as well as to contextualize PRMT biology within the early disuse-evoked events that precede atrophy, which remain largely undefined. Mice were subjected to 6, 12, 24, 72, or 168 h of unilateral hindlimb denervation. Muscle mass decreased by ~30% after 72 or 168 h of neurogenic disuse, depending on muscle fiber type composition. The expression, localization, and activities of PRMT1, PRMT4, and PRMT5 were modified, exhibiting changes in gene expression and activity that were PRMT-specific. Rapid alterations in canonical muscle atrophy signaling such as forkhead box protein O1, muscle RING-finger protein-1, as well as peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) content, AMP-activated protein kinase (AMPK) and p38 mitogen-activated protein kinase, were observed before measurable decrements in muscle mass. Denervation-induced modifications in AMPK-PRMT1 and PGC-1α-PRMT1 binding revealed a novel, putative PRMT1-AMPK-PGC-1α signaling axis in skeletal muscle. Here, PGC-1α-PRMT1 binding was elevated after 6 h of disuse, whereas AMPK-PRMT1 interactions were reduced following 168 h of denervation. Our data suggest that PRMT biology is integral to the mechanisms that precede and initiate skeletal muscle atrophy during conditions of neurogenic disuse. This study furthers our understanding of the role of PRMTs in governing skeletal muscle plasticity.

Entities:  

Keywords:  AMPK; PGC-1α; PRMT; atrophy; p38

Mesh:

Substances:

Year:  2017        PMID: 29092819      PMCID: PMC5866438          DOI: 10.1152/ajpcell.00174.2017

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  58 in total

1.  Mitochondrial adaptations in denervated muscle: relationship to muscle performance.

Authors:  K L Wicks; D A Hood
Journal:  Am J Physiol       Date:  1991-04

Review 2.  Disuse-induced muscle wasting.

Authors:  Sue C Bodine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-22       Impact factor: 5.085

3.  Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle.

Authors:  Vladimir Ljubicic; Shiemaa Khogali; Jean-Marc Renaud; Bernard J Jasmin
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 4.  PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.

Authors:  Vitor A Lira; Carley R Benton; Zhen Yan; Arend Bonen
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-06       Impact factor: 4.310

5.  Global histone modification patterns predict risk of prostate cancer recurrence.

Authors:  David B Seligson; Steve Horvath; Tao Shi; Hong Yu; Sheila Tze; Michael Grunstein; Siavash K Kurdistani
Journal:  Nature       Date:  2005-06-30       Impact factor: 49.962

6.  Exercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1alpha expression.

Authors:  David C Wright; Dong-Ho Han; Pablo M Garcia-Roves; Paige C Geiger; Terry E Jones; John O Holloszy
Journal:  J Biol Chem       Date:  2006-11-12       Impact factor: 5.157

Review 7.  AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs.

Authors:  D Grahame Hardie; Bethany E Schaffer; Anne Brunet
Journal:  Trends Cell Biol       Date:  2015-11-23       Impact factor: 20.808

8.  AMP-activated kinase α2 deficiency protects mice from denervation-induced skeletal muscle atrophy.

Authors:  Yuting Guo; Jin Meng; Yinglong Tang; Ting Wang; Bin Wei; Run Feng; Bing Gong; Huiwen Wang; Guangju Ji; Zhongbing Lu
Journal:  Arch Biochem Biophys       Date:  2016-04-29       Impact factor: 4.013

9.  Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain.

Authors:  Joyce Sayegh; Kristofor Webb; Donghang Cheng; Mark T Bedford; Steven G Clarke
Journal:  J Biol Chem       Date:  2007-10-09       Impact factor: 5.157

Review 10.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

View more
  6 in total

1.  Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.

Authors:  Alexander Manta; Derek W Stouth; Donald Xhuti; Leon Chi; Irena A Rebalka; Jayne M Kalmar; Thomas J Hawke; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

2.  Protein arginine methyltransferase biology in humans during acute and chronic skeletal muscle plasticity.

Authors:  Tiffany L vanLieshout; Jacob T Bonafiglia; Brendon J Gurd; Vladimir Ljubicic
Journal:  J Appl Physiol (1985)       Date:  2019-08-01

Review 3.  The Role of AMPK in the Regulation of Skeletal Muscle Size, Hypertrophy, and Regeneration.

Authors:  David M Thomson
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

4.  Protein arginine methyltransferase expression and activity during myogenesis.

Authors:  Nicole Y Shen; Sean Y Ng; Stephen L Toepp; Vladimir Ljubicic
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

5.  Mechanisms of exercise-induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy-like mice.

Authors:  Sean Y Ng; Andrew Mikhail; Vladimir Ljubicic
Journal:  J Physiol       Date:  2019-08-22       Impact factor: 5.182

Review 6.  A transition to degeneration triggered by oxidative stress in degenerative disorders.

Authors:  Michael Stern; James A McNew
Journal:  Mol Psychiatry       Date:  2020-11-06       Impact factor: 13.437

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.